Leprosy 5

Common Name(s)

Leprosy 5

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Leprosy 5" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Leprosy 5" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Leprosy 5" returned 6 free, full-text research articles on human participants. First 3 results:

Leprosy association with low MASP-2 levels generated by MASP2 haplotypes and polymorphisms flanking MAp19 exon 5.
 

Author(s): Angelica Beate Winter Boldt, Isabela Goeldner, Ewalda R S Stahlke, Steffen Thiel, Jens Christian Jensenius, Iara José Taborda de Messias-Reason

Journal:

 

The gene MASP2 (mannan-binding lectin (MBL)-associated serine protease 2) encodes two proteins, MASP-2 and MAp19 (MBL-associated protein of 19 kDa), bound in plasma to MBL and ficolins. The binding of MBL/MASP-2 and ficolin/MASP-2 complexes to microorganisms activates the lectin pathway ...

Last Updated: 12 Aug 2013

Go To URL
A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy.
 

Author(s): Maria T Ochoa, Rosane Teles, Blake E Haas, Danny Zaghi, Huiying Li, Euzenir N Sarno, Thomas H Rea, Robert L Modlin, Delphine J Lee

Journal: Immunology. 2010 Nov;131(3):405-14.

 

Leprosy is an infectious disease in which the clinical manifestations correlate with the type of immune response mounted to the pathogen, Mycobacterium leprae. To investigate which biological pathways or gene sets are over-represented in lepromatous (L-Lep) versus tuberculoid (T-Lep) ...

Last Updated: 2 Nov 2010

Go To URL
Evaluation of leprosy patients with 1 to 5 skin lesions with relevance to their grouping into paucibacillary or multibacillary disease.
 

Author(s): P Narasimha Rao, Dvs Pratap, A V Ramana Reddy, Suneetha Sujai

Journal: Indian J Dermatol Venereol Leprol. ;72(3):207-10.

 

Patients with 1 to 5 skin lesions are arbitrarily categorized as belonging to the paucibacillary (PB) group for treatment purposes. With the decreasing prevalence of leprosy in India and modifications in leprosy program, the relevance of this grouping needs further study.

Last Updated: 12 Jun 2006

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Leprosy 5" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.